Table 3 Clinical Characteristics of the Study Subjects.
Variables* | Normoalbuminuria n = 1150 | Microalbuminuria n = 226 | Macroalbuminuria n = 38 | p |
|---|---|---|---|---|
Male | 609 (53.0) | 118 (52.2) | 23 (60.5) | 0.631 |
Age (years) | 55.7 ± 10.0 | 58.6 ± 9.6 | 59.6 ± 9.67 | < 0.001 |
Duration of DM (years) | 5.2 ± 6.1 | 6.6 ± 6.6 | 8.9 ± 6.2 | < 0.001 |
BMI (kg/m2) | 25.5 ± 3.9 | 24.9 ± 4.5 | 23.5 ± 3.8 | 0.004 |
SBP (mm of Hg) | 137.4 ± 19.9 | 145.6 ± 22.8 | 150.4 ± 23.0 | < 0.001 |
DBP (mm of Hg) | 81.5 ± 11.2 | 84.0 ± 11.5 | 83.8 ± 12.9 | 0.005 |
HbA1c (gm %) | 8.0 ± 2.1 | 9.0 ± 2.3 | 9.0 ± 2.3 | < 0.001 |
Serum TC | 186.1 ± 40.4 | 186.8 ± 39.3 | 196.5 ± 56.9 | 0.299 |
Serum HDL | 39.2 ± 10.2 | 38.8 ± 9.3 | 42.5 ± 13.2 | 0.119 |
Serum TGL | 153.4 ± 104.4 | 156.1 ± 80.4 | 148.9 ± 75.2 | 0.896 |
Presence of DR | 162 (14.1) | 70 (31.0) | 23 (60.5) | < 0.001 |
Presence of Sight threatening DR | 16 (9.9) | 15 (21.4) | 14 (60.9) | < 0.001 |